JA
Jagadevi Anilreddy Lyagal
About Jagadevi Anilreddy Lyagal
Data last updated:
Jagadevi Anilreddy Lyagal is a Director at Occumai Technologies Private Limited (since 2021), Designated Partner at Curexo Pharma Llp (since 2026) and Director at Genaiology Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Information Technology and Outsourcing. The largest current company by reported revenue is Occumai Technologies Private Limited at ₹28.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Occumai Technologies Private Limited U72900MH2021PTC361237 | Director | 29 May 2021 | 2021 | ₹28.3 Lakh (FY 2025) | Active |
| Curexo Pharma Llp ACY-9398 | Designated Partner | 03 Jun 2026 | 2026 | Active | |
| Genaiology Private Limited U62011MH2025PTC462303 | Director | 08 Dec 2025 | 2025 | Active | |
| R4ai Consulting Services Private Limited U62010MH2024PTC435711 | Director | 28 Nov 2024 | 2024 | Active |
Board colleagues of Jagadevi Anilreddy Lyagal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Musaligari Anuradha Reddy | 09187959 | Occumai Technologies Private Limited , Genaiology Private Limited | Director |
| Sunil Annarao Karadkhele | 11756563 | Curexo Pharma Llp | Designated Partner |
| Kiran Shivdas Rathod | 03118747 | R4ai Consulting Services Private Limited | Director |
| Ravi Shivdas Rathod | 10854585 | R4ai Consulting Services Private Limited | Director |
| Sumitra Ravi Rathod | 10854584 | R4ai Consulting Services Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jagadevi Anilreddy Lyagal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jagadevi Anilreddy Lyagal
Jagadevi Anilreddy Lyagal currently holds 4 directorships: Occumai Technologies Private Limited (Director, since 29 May 2021, revenue ₹28.3 Lakh (FY 2025)); Curexo Pharma Llp (Designated Partner, since 03 Jun 2026); Genaiology Private Limited (Director, since 08 Dec 2025); R4ai Consulting Services Private Limited (Director, since 28 Nov 2024).
Jagadevi Anilreddy Lyagal was first appointed on 29 May 2021 as Director at Occumai Technologies Private Limited. The most recent appointment on record is 03 Jun 2026 at Curexo Pharma Llp.
The current boards of Jagadevi Anilreddy Lyagal's companies include Musaligari Anuradha Reddy (Occumai Technologies Private Limited), Sunil Annarao Karadkhele (Curexo Pharma Llp), Kiran Shivdas Rathod (R4ai Consulting Services Private Limited), Ravi Shivdas Rathod (R4ai Consulting Services Private Limited), Sumitra Ravi Rathod (R4ai Consulting Services Private Limited).